Skip to main content
ASPI logo

ASPI · ASP Isotopes Inc.

Track ASPI — free
$2.79 -0.07 (-2.45%)
Market Cap
$413.17M
Shares
153.31M
Volume · Oct 7 4.23M Avg daily vol (3M) 3.98M

Price & Indicators

Drag to pan · scroll to zoom
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$2.86 Open$2.76 Day$2.69–2.90 52W close$2.60–14.05 Avg vol 30d4.3M Short int26.1M · 17.0% float · 6.5d Short vol52% Last earningsApr 13, 2026 DataNov 2022–Oct 2026 Filing10-Q · Aug 14

Up next

filed Aug 14, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
—
Year over year · more shares
Price change (1Y)
-67.8%
Trailing year
Short interest
17.0%
Latest settlement · 6.5 days to cover
View all 115 metrics

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Sell Momentum Very Weak Sentiment Neutral Fundamentals Fair Quant / Vol Very High
Market backdrop VIX 15.1 · calm Equity put/call 0.63
Technical
price trend
Sell
50 / 200-day cross No cross
Price vs 200-day avg −45%
below
Price vs 50-day avg −21%
below
RSI (14) 38
neutral
MACD trend Positive
52-week position 2%
near low
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Very Weak
1-month return −25%
trailing
6-month return −44%
trailing
YTD return −47%
this year
Relative strength −55%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $4 › 200d $5 — 200d above 50d
Institutional flow Accumulating
2 of 189 funds reported for Sep 30 · net +928 sh shares
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
17.00% of float · ▲ +2.3% MoM · 6.5 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
189 holders — near 3-yr high, broad support
Squeeze score 67
elevated · 0–100
Fundamentals
Fair
Revenue growth +476%
Y/Y
Gross margin 14%
contracting
EPS growth −235%
Y/Y
Free cash flow $-47.4M
Buyback $13.8M
authorized
Balance sheet $277.5M
net cash
Quant / Vol
risk profile
Very High
Volatility 106%
annualized · 1-yr
Max drawdown −81%
past year
ATR 8.1%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Latest guidance · from the 8-K filed Aug 4, 2026
FY 2026
FY 2026 revenues Initiated $14M
after the expected completion of Phase 1
Annualized forecasted helium and LNG revenues $27M
after the expected completion of Phase 1 (annualized basis)
Revenues at least $27M
at nameplate capacity of Phase 2
Annual revenues at least $360M

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Sell
3 · 3 · 1
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−45% Bearish
Price vs 50-day avg
−21% Bearish
RSI (14)
38 Neutral
MACD trend
Positive Bullish
52-week position
2% Bearish
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross) No cross
50d $4 › 200d $5 — 200d above 50d
Institutional flow Accumulating
2 of 189 funds reported for Sep 30 · net +928 sh shares
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
17.00% of float · ▲ +2.3% MoM · 6.5 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
189 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $3 Now $3 · 2% Range high $14
vs 200-day avg -45% vs 50-day avg -21%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.

Versus peers

Specialty Chemicals — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
ASPI
ASP Isotopes Inc.
this stock
$413.17M -46.5% +475.5% — 17.0%
LIN
Linde PLC
$223.11B +13.5% +3.0% 31.2 1.3%
AIQUF
L Air Liquide SA /Fi
$120.27B +0.4% — — 0.0%
ECL
Ecolab Inc.
$77.67B +5.9% +2.2% 37.2 1.9%
SHW
Sherwin Williams Co
$76.47B -2.8% +2.1% 29.1 2.6%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
188
% held
48.8%
Reported
2 of 189
Top holder
BlackRock, Inc.
Held Float
View
Held by Funds
Fund positions
119
View
Short & Settlement
Short Interest Rising
Shares short
26.1M
Days to cover
6.5d
Change
+588.3K sh
View
Short Volume
Short vol %
52%
As of
Oct 7, 2026
Short Total
View
Fails to Deliver
FTD shares
814
Value
$2.7K
As of
Sep 14, 2026
View
Off-Exchange
Off-exchange %
44.7%
Week of
Aug 31, 2026
Off-exch Lit
View
Financials
Financials
Revenue (FY)
$23.8M
Net income (FY)
$-159.8M
EPS diluted
$-2.11
View
Buybacks
Authorized · 2 programs
$13.8M
View
Filings
SEC Filings
Latest
8-K
Filed
Oct 2, 2026
This year
41
View
Proposed Sales
Value
$316.6K
Shares
83.8K
Filed
Sep 2, 2026
View
Exempt Offerings
Offering
$109.2M
Filed
Jul 17, 2026
View
Earnings & Events
Webcasts
Last webcast
Sep 8, 2026
View

Performance

5D 20D 120D MTD YTD
ASPI +7.9% -25.1% -44.0% +7.9% -46.5%
SPY +1.9% +1.9% +10.8% +1.9% +14.0%
vs SPY +6.0% -27.1% -54.8% +6.0% -60.5%

Capital returns

Buyback programs · 2 active · as of May 27, 2026
Authorized (total)
$13.80M
Spent (derived)
—
Remaining
—

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 1921865 CUSIP 00218A105 13F (30d) 4 filings 4 filers Visit website Investor relations